Dyax - Advancing Novel Biotherapeutics

Executive Officer


Ivana Magovčević-Liebisch, Ph.D., J.D.

Executive Vice President Corporate Development and General Counsel

 

Dr. Magovcevic-Liebisch is Dyax's Executive Vice President Corporate Development and General Counsel and has served as an executive officer of the Company since December 2005. In addition to overseeing the Legal and Business Development departments within Dyax, she also manages the Corporate Communications department and acts as Assistant Secretary of the Board of Directors. She joined Dyax in April 2001 as Vice President of Intellectual Property and has held several different positions within the Company.

Dr. Magovcevic-Liebisch was Director of Intellectual Property and Patent Counsel for Transkaryotic Therapies, Inc. from 1998 to 2001. Previously, she worked at Fish and Richardson and Lahive & Cockfield, two Boston patent law firms. Dr. Magovcevic-Liebisch holds a doctorate in genetics from Harvard University and a law degree from Suffolk University.


You are now leaving Dyax.com.
The web site you are about to visit is neither owned nor controlled by Dyax Corp. Dyax Corp. is not responsible for the content, products or services on this site.

Do you wish to continue?